Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Accuray Inc (NQ: ARAY )

5.150 USD +0.070 (+1.38%)
Official Closing Price Updated: 7:58 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Accuray Inc

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
Advanced, 10-Day Radiation Treatment Regimen Enables Patients to Get Back to Their Life, Faster 
From PR Newswire
Accuray to Report Second Quarter Fiscal 2021 Financial Results on January 27, 2021
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market close on Wednesday January 27, 2021. Management... 
From PR Newswire
Accuray To Participate at J.P. Morgan's 39th Annual Healthcare Conference
Company to present on Thursday, January 14, 2021 at 11 am PT / 2 pm ET 
From PR Newswire
Accuray Receives 510(k) FDA Clearance for ClearRT™ Helical kVCT Imaging for the Radixact® Treatment Delivery System
New Option will Provide an Efficient, Versatile and Cost-Effective Approach for Obtaining Exceptional Quality Images 
From PR Newswire
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Jim Dennison, the company's new Senior Vice President, Quality & Regulatory... 
From PR Newswire
Accuray and DHL Supply Chain establish global service logistics platform to support delivery of advanced cancer treatment technology
Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts logistics partnership that will further strengthen the Accuray aftermarket supply... 
From PR Newswire
Accuray Appoints Renowned Medical Device Industry Executive Jim Dennison as Senior Vice President of Global Quality and Regulatory Affairs
Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Jim Dennison as its senior vice president of global quality and regulatory affairs, effective immediately. Mr. Dennison is an... 
From PR Newswire
Accuray Showcases Radiation Therapy Innovations Designed to Enable Better Outcomes with Less Damage, Less Time, and Less Cost, at ASTRO 2020
ASTRO Studies Focused on (Ultra) Hypofractionated Treatments Were Shared, Highlighting Experience of >1,400 Patients 
From PR Newswire
Accuray Reports First Quarter Fiscal 2021 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2021 ended September 30, 2020. 
From PR Newswire
Accuray Announces Agreement with Brainlab to Expand CyberKnife® Platform Treatment Capabilities for the Neuro-Radiosurgery Market
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform 
From PR Newswire
Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Mike Leischer as its vice president and general manager, Americas (AMS) region, effective immediately. In this role, he will provide... 
From PR Newswire
Accuray To Report First Quarter Fiscal 2021 Financial Results on October 29, 2020
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2021, ended September 30, 2020, after the market close on Thursday, October 29, 2020. Management... 
From PR Newswire
Accuray to Host ASTRO Analyst & Investor Meeting on October 26, 2020
Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst & Investor Meeting on Monday, October 26th, 2020 in conjunction with the American Society of Radiation Oncology... 
From PR Newswire
Accuray Radixact® System with Synchrony® Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
- First lung case in ASIA, and the first liver case in the world, were treated at Takarazuka City Hospital, Hyogo, Japan 
From PR Newswire
Accuray to Present at Lake Street Capital Markets' 4th Annual Best Ideas Growth Conference
Virtual event to take place on September 17, 2020 
From PR Newswire
University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology
Renowned Hospital in Turin, Italy Uses Innovative Radiation Therapy Delivery System to Expand Options for Advanced Cancer Care to More Patients 
From PR Newswire
Accuray Reports Fourth Quarter and Fiscal 2020 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2020. 
From PR Newswire
Anne B. Le Grand Joins Accuray Board of Directors
Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020. In addition, she will serve on the Board's... 
From PR Newswire
Accuray To Report Fiscal Year-end 2020 Financial Results on August 13, 2020
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020. Management... 
From PR Newswire
Accuray Launches New CyberKnife® S7™ System
Geisinger Wyoming Valley Medical Center is First in the World to Treat Patients with the New System 
From PR Newswire
Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System Wins 2020 MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies 
From PR Newswire
Accuray Reports Fiscal 2020 Third Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020. 
From PR Newswire
Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review... 
From PR Newswire
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Michael Hoge, the company's new Senior Vice President, Global Operations. As a... 
From PR Newswire
First Accuray CyberKnife® M6™ System Installed in Missouri at Mercy Hospital St. Louis
Accuray Incorporated (NASDAQ: ARAY) announced today that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife®... 
From PR Newswire
Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy® System in the treatment of advanced rectal cancer. Radiotherapy, with or without... 
From PR Newswire
Accuray Reports Fiscal 2020 Second Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019. 
From PR Newswire
Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020
Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to... 
From PR Newswire
Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
Company to present on Wednesday, January 15, 2020 at 10 am PT / 1 pm ET 
From PR Newswire
Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.